Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
201 studies found for:    Open Studies | "Hypertension, Pulmonary"
Show Display Options
Rank Status Study
21 Recruiting Trimetazidine in Pulmonary Artery Hypertension
Condition: Pulmonary Artery Hypertension
Intervention: Drug: Trimetazidine
22 Not yet recruiting Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Device: Noninvasive cardiac output monitor (NICOM)
23 Recruiting Investigation of Dysynchrony in Patients With Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Procedure: Catheterization Pacing
24 Not yet recruiting Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: Regadenoson
25 Recruiting PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Mitral Valve Surgery
Interventions: Drug: Sildenafil;   Drug: Placebo
26 Recruiting the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Condition: Pulmonary Hypertension
27 Not yet recruiting Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery
Condition: Pulmonary Hypertension
Interventions: Drug: Remodulin;   Drug: distilled water
28 Not yet recruiting A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
Condition: Pulmonary Artery Hypertension
Interventions: Drug: reserpine;   Procedure: stellate ganglion block;   Drug: lidocaine
29 Recruiting Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Rehabilitation on Physical Condition, Body Composition and Health Related Quality of Life
Condition: Pulmonary Hypertension: Efficacy of Rehabilitation
30 Recruiting Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)
Condition: Pulmonary Hypertension
31 Recruiting Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
Condition: Pulmonary Hypertension
Interventions: Drug: Macitentan 10mg;   Drug: Placebo sugar pill
32 Not yet recruiting Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects
Condition: Pulmonary Hypertension
Intervention: Drug: fludeoxyglucose
33 Recruiting Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
Condition: Residual Pulmonary Hypertension
Interventions: Drug: Ventavis;   Drug: Warfarin
34 Recruiting Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Conditions: Hypertension, Pulmonary;   Heart Failure With Normal Ejection Fraction
Interventions: Drug: Riociguat;   Drug: Placebo
35 Recruiting Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases
Condition: Pulmonary Hypertension
36 Recruiting Registry for Pulmonary Hypertension Due to Left Heart Disease in China
Condition: Pulmonary Hypertension Due to Left Heart Disease
Intervention: Other: Routine therapy
37 Not yet recruiting Cardiac MRI in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Device: Magnetic resonance Imaging
38 Recruiting PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Condition: Persistent Pulmonary Hypertension
39 Recruiting A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.
Conditions: Myeloproliferative Disease;   Pulmonary Hypertension
Intervention: Other: myeloproliferative disease
40 Recruiting Macitentan in Pulmonary Hypertension of Sickle Cell Disease
Conditions: Pulmonary Hypertension;   Sickle Cell Disease
Intervention: Drug: macitentan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.